Status:
TERMINATED
Validation of a Quality of Life Metric "Prolac-10"
Lead Sponsor:
Ohio State University
Conditions:
Prolactinoma
Prolactin-Producing Pituitary Tumor
Eligibility:
All Genders
18+ years
Brief Summary
This is a short-term validation study of a quality of life metric "Prolac-10" for patients diagnosed with a prolactinoma, undergoing new medical therapy.
Detailed Description
This is a single-site validation study of a novel quality of life study for patients undergoing medical therapy for prolactinoma. Patients will be consented before starting their medical regimen and c...
Eligibility Criteria
Inclusion
- Patient has been diagnosed with prolactinoma by use of appropriate blood tests and brain imaging.
- 18 years of age or older
- The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
Exclusion
- Patient is a prisoner
- Patient is not English speaking
- Patient has been previously treated for prolactinoma
- Patient is pregnant at time of diagnosis and treatment
Key Trial Info
Start Date :
October 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04106531
Start Date
October 15 2019
End Date
June 13 2023
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University
Columbus, Ohio, United States, 43210